Despite recent advances in immunotherapy and targeted therapy, most patients with non-small-cell lung cancer (NSCLC) continue to have disease progression and develop resistance to current treatments.
Microplastics (MP) are the subject of intensive medical research, but little is yet known about their effects on the immune ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. You snore because your airway was redesigned for language. That structural trade-off has ...
Czech researchers have discovered that nanoplastics can weaken the lungs’ natural defence system, raising fresh concerns ...
The couple “left it to God”, as an anxious team got to work at Moradabad’s TMU Hospital for a '1 in 7 lakh' delivery. A week ...
Learn why the unique avian respiratory anatomy make breathing efficient yet infection-prone, plus how CT imaging detects ...
Savara Presented New Biomarker Data from the IMPALA-2 Phase 3 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) ...
ORJ-001 achieved therapeutic exposure and was well tolerated in Phase 1 study, supporting company’s plans to initiate Phase 2 clinical trial in IPF patients ...
SIBO diagnosis once relied on invasive culture, but breath testing now offers a simpler option despite early standardization ...
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the first quarter ending March 31, 2026 and provided a ...
The lung is not only a gas-exchange organ but also a highly specialized lipid-rich immunological interface. The COVID-19 era, together with continued work on bacterial pathogenesis and inflammation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results